BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.

NCT01072968 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea
Excessive Daytime Sleepiness

Interventions

DRUG: BF2.649
DRUG: Placebo

Sponsor

Bioprojet